Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Jul 29, 2026
Why Is Lennox International (LII) Stock Down -15.87% Today?

Why Is Lennox International (LII) Stock Down -15.87% Today?

Key Takeaways

  • Lennox International shares plunged 15.87% in intraday trading Wednesday, falling to $457.76 from a prior close of $544.11.
  • The primary catalyst was the company's Q2 2026 earnings report, which featured a slight revenue miss and a downward revision to full-year EPS guidance.
  • Residential market softness weighed heavily on the company's Home Comfort Solutions segment, where revenue declined 7% year-over-year and segment profit fell 12%.
  • Full-year EPS guidance was trimmed to a range of $23.00–$24.00, down from the prior $23.50–$25.00, with the midpoint falling roughly 4.7% below analyst consensus.
  • Building Climate Solutions showed strength with 24% revenue growth, but it was not enough to offset investor concerns about residential headwinds and margin pressures.
  • Traders are now watching for signs of stabilization in residential HVAC demand, tariff developments, and progress on acquisition integrations in the quarters ahead.

Opening Summary

Shares of LII, Lennox International Inc.—a Texas-based global leader in energy-efficient heating, ventilation, air conditioning, and refrigeration (HVACR) solutions—tumbled 15.87% during Wednesday's trading session. The stock dropped to $457.76 intraday from Tuesday's closing price of $544.11, erasing billions in market capitalization. The selloff was triggered by the company's second-quarter 2026 earnings report, released before the market opened, which revealed a modest revenue shortfall relative to Wall Street expectations and, more critically, a reduction in the company's full-year profit forecast. The results underscored persistent headwinds in the residential HVAC market that overshadowed robust performance in Lennox's commercial building segment.

Q2 Earnings: Revenue Misses, Guidance Disappoints

Lennox reported second-quarter revenue of $1.55 billion, up 3% year-over-year but narrowly below the $1.56 billion consensus estimate. GAAP diluted earnings per share came in at $7.72, essentially flat compared to $7.71 a year earlier and in line with analyst projections. While the top-line miss was modest, the real shock came from updated forward guidance. The company revised its full-year 2026 GAAP EPS outlook to a range of $23.00 to $24.00, down from the prior range of $23.50 to $25.00. At the midpoint of $23.50, the new guidance sat approximately 4.7% below the Street's consensus, signaling that management expects macro headwinds to persist longer than previously anticipated.

Operating income rose 2% to $355 million, but the total segment margin contracted 30 basis points to 23.0%. Net income slipped to $269 million from $274 million in the prior-year quarter. On a positive note, operating cash flow improved significantly to $172 million from $87 million a year ago, driven by reduced inventory levels, and the company repurchased $132 million in shares during the quarter.

Residential Weakness Offsets Commercial Strength

The two-speed nature of Lennox's business was on full display in the Q2 results. The Home Comfort Solutions segment—which serves the residential market—saw revenue decline 7% year-over-year to $936 million, with segment profit dropping 12% to $222 million. Segment margin contracted 130 basis points to 23.7%, pressured by lower sales volumes and factory under-absorption. Management pointed to challenging residential market conditions, with new construction activity remaining a "meaningful headwind." While demand improved sequentially from the first quarter and pricing actions largely offset inflationary and tariff pressures, the segment's profit headwinds from lower volumes totaled $49 million.

In stark contrast, the Building Climate Solutions segment delivered standout results, with revenue surging 24% to $610 million and segment profit jumping 29% to $155 million. Organic revenue growth of 15% was fueled by strong execution with national account customers, healthy emergency replacement activity, and expanding service offerings. Acquisitions contributed an additional 9% to revenue growth. Despite this strength, the market's laser focus on the much larger residential segment's struggles drowned out the commercial unit's success.

Guidance Cut and Tariff Uncertainty

The downward revision to full-year EPS guidance signals that Lennox's management expects cost inflation, factory under-absorption, and residential demand softness to linger through the second half of 2026. While the company reaffirmed its revenue growth target of approximately 8% (including a 5% benefit from completed acquisitions), the profit outlook downgrade suggests margin recovery will take longer than previously modeled. Tariff dynamics also injected uncertainty: while Lennox benefited from $30 million in earlier-than-expected tariff refunds during the quarter, ongoing tariff policy unpredictability and related pricing actions remain a key variable for the company's cost structure going forward.

Market Context and Trading Activity

Wednesday's selloff was accompanied by exceptionally heavy trading volume. The prior session on Tuesday had already seen roughly 1.0 million shares change hands—more than double the stock's 90-day average volume of approximately 434,000—as traders positioned ahead of earnings. Wednesday's intraday activity suggested even more elevated participation as institutional investors reassessed positions following the guidance cut. The magnitude of the drop far exceeded typical moves in the building products and HVAC sector, indicating a genuine repricing of risk rather than broad market sympathy. Broader industrial and building product peers showed relatively muted moves, confirming that the LII selloff was company-specific rather than sector-driven.

From a technical standpoint, the stock sliced through several key levels, including its 50-day moving average (which had been near $528) and its 200-day moving average (near $516), landing at levels not seen since the spring of 2026. The break below these widely watched technical markers likely accelerated selling pressure as stop-loss orders and algorithmic trading programs were triggered.

What Comes Next for LII

Looking ahead, Lennox's path to recovery depends on several interconnected factors. First, stabilization in the residential HVAC market—particularly an uptick in new construction activity and homeowner replacement demand—will be critical to reversing the Home Comfort Solutions segment's volume declines. Second, the pace and success of integrating recent acquisitions, including Duro Dyne, Supco, and the newly acquired Comfort-Aire and Century brands, will be closely monitored for their contribution to both revenue and margin profiles. Third, the trajectory of tariffs and input costs will directly influence the company's pricing power and cost absorption. On the positive side, Lennox's strong free cash flow generation (targeted at $750–$850 million for the full year), disciplined share repurchase program, and the momentum in Building Climate Solutions provide financial flexibility and a buffer against residential market weakness. Still, with residential softness persisting and the guidance revision fresh in investors' minds, the stock may face continued scrutiny until tangible signs of a residential demand recovery materialize.

Trending AI Robots

In volatile market conditions like those affecting Lennox today, some traders turn to automated strategies for data-driven decision-making. Tickeron's Trending AI Robots page features a curated selection of AI-powered trading bots that have demonstrated strong performance under current market conditions. With hundreds of bots covering thousands of tickers and employing strategies ranging from swing trading to long-term trend following, the platform identifies only the top performers for its Trending section. Each bot varies by strategy type, timeframe, performance metrics, and traded symbols, offering traders a diverse toolkit. Explore the Trending AI Robots page to discover which automated strategies are navigating today's market most effectively.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: LII

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


LII in +2.39% Uptrend, growing for three consecutive days on September 23, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where LII advanced for three days, in 220 of 331 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where LII's RSI Oscillator exited the oversold zone, 15 of 25 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 60%.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 33 of 58 cases where LII's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 57%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 02, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on LII as a result. In 59 of 89 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 66%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LII declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 68%.

The Aroon Indicator for LII entered a downward trend on September 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 17 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 46 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.814) is normal, around the industry mean (9.236). P/E Ratio (16.367) is within average values for comparable stocks, (38.255). Projected Growth (PEG Ratio) (0.934) is also within normal values, averaging (1.212). Dividend Yield (0.014) settles around the average of (0.009) among similar stocks. P/S Ratio (2.387) is also within normal values, averaging (2.201).

The Tickeron PE Growth Rating for this company is 71 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 80 (best 1 - 100 worst), indicating slightly worse than average price growth. LII’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 87 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LII’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock worse than average.

Notable companies

The most notable companies in this group are Johnson Controls International plc (NYSE:JCI), Owens Corning (NYSE:OC), Alpha Pro Tech Ltd (ASE:APT).

Industry description

The industry manufactures products used in the construction of residential and commercial buildings. The process involves using materials and other products, and processing them to create finished items such as doors, windows, light fittings, floor coverings, climate control products and other building components and home improvement products. Masco Corporation, Allegion PLC and Lennox International Inc. are major manufacturers of such products.

Market Cap

The average market capitalization across the Building Products Industry is 10.05B. The market cap for tickers in the group ranges from 1.88K to 99.46B. TT holds the highest valuation in this group at 99.46B. The lowest valued company is STAI at 1.88K.

High and low price notable news

The average weekly price growth across all stocks in the Building Products Industry was -0%. For the same Industry, the average monthly price growth was -7%, and the average quarterly price growth was -1%. AEHL experienced the highest price growth at 32%, while JLHL experienced the biggest fall at -33%.

Volume

The average weekly volume growth across all stocks in the Building Products Industry was -2%. For the same stocks of the Industry, the average monthly volume growth was 3% and the average quarterly volume growth was -20%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 56
P/E Growth Rating: 52
Price Growth Rating: 59
SMR Rating: 67
Profit Risk Rating: 77
Seasonality Score: 12 (-100 ... +100)
View a ticker or compare two or three
LII
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of broad range of products for the heating, ventilation, air conditioning and refrigeration markets

Industry BuildingProducts

Industry
Building Products
Address
2140 Lake Park Boulevard
Phone
+1 972 497-5000
Employees
12900
Web
https://www.lennox.com
Interact to see
Advertisement
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
Lifetime Brands (LCUT) stock surged +77% over the last 30 days, driven by a strong Q4 earnings beat and a Zacks Rank #1 (Strong Buy) upgrade that reflects an improved earnings outlook. Over the past quarter, shares rose +48%, supported by profitability gains despite softer sales, with adjusted EBITDA reaching $50.8 million for full-year 2025.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
ARM stock surged +26% over the past 30 days, driven by announcements of in-house chip production and strong analyst upgrades amid AI enthusiasm. Over the past quarter, the stock climbed +38%, reflecting robust Q3 earnings beat with 26% revenue growth and data center royalty doubling.
Sable Offshore Corp. (SOC) is an independent oil and gas company focused on offshore operations in federal waters off California. The company owns and operates three platforms in the Santa Ynez Unit (SYU), spanning 16 federal leases across approximately 76,000 acres, along with subsea pipelines for crude oil, natural gas, and produced water transport to onshore facilities. Its core business model centers on restarting and developing prolific fields like the SYU, which had been idle due to regulatory and legal hurdles following a 2015 pipeline spill.
Patterson-UTI Energy, Inc. (PTEN) stands out as a leading provider of drilling and completion services to oil and natural gas exploration and production companies, primarily in the United States and select international markets. The company operates through three main segments: Drilling Services, which includes contract drilling rigs and directional drilling; Completion Services, encompassing hydraulic fracturing, wireline, and pumping; and Drilling Products, offering specialized drill bits globally, including in the Middle East.
As a provider of onshore drilling and completion services, Patterson-UTI Energy (PTEN) is gearing up for a key Q1 2026 earnings report against the backdrop of fluctuating oil prices and steady U.S. rig demand. The company's integrated approach across Drilling Services, Completion Services, and Drilling Products gives it a solid footing in North American shale plays. In my view, recent quarters like Q4 2025, where revenue exceeded estimates despite a net loss, highlight its resilience. This upcoming report will offer insights into activity levels, margin trends, and capital discipline amid supply growth and geopolitical tensions. With strong free cash flow and recent dividend increases, PTEN's focus on shareholders stands out, making this a critical gauge for the 2026 outlook in the cyclical oilfield services sector.
When geopolitical turmoil sends markets into chaos, most retail traders freeze — but Tickeron's Energy (OXY, EOG, DVN, FANG, APA, MTDR) AI Trading Agent is built to thrive in exactly these conditions. This 15-minute and 60-minute AI-powered robot has delivered a +76.22% annualized return with a 64.21% win rate and a Profit Factor of 2.70 — trading six of the most volatile and opportunity-rich energy tickers on the market.
The global energy sector is on fire — literally and figuratively. With crude oil prices swinging 20–30% in response to geopolitical flashpoints, OPEC+ production cuts, and escalating conflicts in Eastern Europe and the Middle East, traders who aren't using AI-powered tools are flying blind. Enter Tickeron's Energy (Oil & Gas – E&P) AI Trading Agent — a 60-minute signal robot built exclusively around five high-impact Exploration & Production tickers, now posting a staggering +49% Annualized Return and +1,251% 30-Day Annualized Return, with $14,703 in closed-trade P&L on a $30,000 simulated balance.
From what I see, Cheniere Energy Partners (CQP) holds a commanding position through its ownership and operation of the Sabine Pass LNG terminal in Louisiana, the largest LNG production facility in the U.S. with approximately 30 million tonnes per annum (mtpa) capacity across six trains, alongside the connected Creole Trail Pipeline. This setup makes CQP a leader in U.S. LNG exports, which have accounted for about 11% of global supply in recent years. The company's ~80% contracted production through long-term sale and purchase agreements (SPAs) provides revenue stability, with weighted average remaining lives of around 13 years.
In my view, Regeneron Pharmaceuticals holds a strong leadership position in biotechnology, thanks to its proprietary VelociSuite technologies, including VelocImmune for fully human antibody discovery. This enables a robust pipeline across immunology, oncology, ophthalmology, and rare diseases. The company's integrated model—from discovery to commercialization—drives high R&D productivity, with approximately 45 clinical programs and key partnerships like Sanofi for Dupixent and Bayer for EYLEA.
As I review argenx SE's place in the market, its strong footing in immunology stands out. This commercial-stage biopharmaceutical company focuses on differentiated antibody therapies for severe autoimmune diseases. The flagship product, VYVGART (efgartigimod), a first-in-class neonatal Fc receptor (FcRn) inhibitor, has secured leadership in generalized myasthenia gravis (gMG) and chronic inflammatory demyelinating polyneuropathy (CIDP), with approvals across the U.S., Europe, and Japan. The Immunology Innovation Program (IIP) fuels a robust pipeline, featuring next-generation FcRn candidates like ARGX-213 and ARGX-124, alongside first-in-class assets such as empasiprubart (C2 inhibitor, ARGX-117) and adimanebart (MuSK agonist).
I've long admired Alnylam Pharmaceuticals as the pioneer in RNA interference (RNAi) therapeutics, a gene-silencing technology that has delivered six approved products, including AMVUTTRA (vutrisiran), ONPATTRO (patisiran), GIVLAARI (givosiran), and OXLUMO (lumasiran). The company's proprietary platform, enhanced by GalNAc conjugation for liver targeting and emerging extra-hepatic delivery innovations, creates a solid competitive moat in precision genetic medicines.
As I review BeOne Medicines AG's position in the oncology space, what stands out is its role as a global leader with a diversified portfolio that includes both commercial-stage therapies and a deep pipeline targeting hematologic and solid tumors. The flagship product, BRUKINSA (zanubrutinib), a Bruton's Tyrosine Kinase (BTK) inhibitor, has secured approvals in over 75 markets, solidifying its dominance in chronic lymphocytic leukemia (CLL) and other blood cancers. This is complemented by TEVIMBRA (tislelizumab), an anti-PD-1 antibody approved in more than 50 markets for various indications, which broadens its reach in immunotherapy.
Rio Tinto holds a premier position as one of the world's largest mining companies, anchored by low-cost, Tier 1 assets. Its Pilbara iron ore operations in Australia deliver industry-leading margins, thanks to integrated rail and port infrastructure that gives it a structural cost advantage over higher-cost producers. In copper, the company has significant stakes in Escondida, the world's largest copper mine, and full ownership of Oyu Tolgoi in Mongolia, setting it up well to benefit from tightening supply as demand surges for electrification and renewables.